# MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer

> **NCT06980506** · — · AVAILABLE · sponsor: **Monopar Therapeutics**

## Conditions studied

- Cancer
- Solid Tumor
- Solid Tumor, Adult

## Interventions

- **DIAGNOSTIC_TEST:** MNPR-101-DFO*-89Zr

## Key facts

- **NCT ID:** NCT06980506
- **Lead sponsor:** Monopar Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06980506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06980506, "MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06980506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*